Bluebird Bio (BLUE) Posts 108% Revenue Growth in Q1 2025 Amid Acquisition Buzz
Bluebird bio Inc. (NASDAQ:BLUE) is a trailblazing biotechnology company that has spent more than a decade at the…
Incyte (INCY) is the Next Big Biotech Winner
Incyte Corporation (NASDAQ:INCY) is a globally recognized, innovation-driven biopharmaceutical company committed to discovering, developing, and commercializing novel therapeutics…
Neurocrine (NBIX) is a Stock to Buy
Neurocrine Biosciences Inc. (NASDAQ:NBIX) is a leading neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing treatments…
Gilead Sciences (GILD) is a Top Long-Term Biotech Investment for 2025
Gilead Sciences Inc. (NASDAQ:GILD) is a leading global biopharmaceutical company renowned for its transformative contributions to antiviral medicine…
Amgen (AMGN) Remains a Cornerstone in Biotech Investing
Amgen Inc. (NASDAQ:AMGN) is one of the world’s most prominent biotechnology companies, renowned for its trailblazing work in…
Denali Therapeutics: The Future of Neuroscience Innovation
Denali Therapeutics Inc. (NASDAQ:DNLI) is building one of the most ambitious and promising pipelines in biotech, with a…
Spok Holdings: A Top Healthcare Communication Stock to Watch in 2025
Spok Holdings Inc. (NASDAQ:SPOK) is emerging as one of the most compelling under-the-radar healthcare communication technology companies in…
Allogene Therapeutics (ALLO): The Future of Off-the-Shelf CAR T Cancer Therapy
Allogene Therapeutics Inc. (NASDAQ:ALLO) is quietly building a revolutionary foundation in the biotech world through its groundbreaking work…
Investors Are Watching XOMA Ahead of 2025’s Major Clinical Readouts
XOMA Royalty Corporation (NASDAQ:XOMA) has emerged as one of the most compelling and strategically positioned companies in the…
Pathology and Oncology Research Publishes Landmark Phase 3 Study: Multikine Immunotherapy Significantly Improves Survival and Quality of Life in Head and Neck Cancer Patients
Recent advancements in cancer immunotherapy have brought promising news for patients battling head and neck squamous cell carcinoma…
Aptose Biosciences (APTO) Stock Soars 31.50%: A Penny Stock on the Rise
Aptose Biosciences (APTO) is a clinical-stage precision oncology company dedicated to addressing unmet needs in hematologic malignancies. The…
CEL-SCI Corporation: Leading the Future of Cancer Immunotherapy with Multikine®
CEL-SCI Corporation is a biotechnology leader committed to revolutionizing cancer treatment through innovative immunotherapy approaches. Founded in 1983…
Ginkgo Bioworks (DNA): A Leader in Synthetic Biology Driving Innovation in 2024
Founded in 2008 by a team of visionary scientists from MIT, Ginkgo Bioworks Holdings Inc. (DNA) has emerged…
Hyperfine (HYPR)’s Swoop® Portable MRI: Transforming Emergency Neurological Care
Hyperfine Inc. (HYPR) is at the forefront of transforming brain imaging with its groundbreaking Swoop® Portable MRI System,…
Quantum-Si (QSI) Stock Soars: QSI Can Be the Future of Protein Sequencing
Quantum-Si Incorporated (QSI) is a revolutionary life sciences company that is transforming the field of proteomics through cutting-edge…
Lan Su, COO of Lakeside Holding, Shares His Vision and Strategies for Charting New Horizons
Biotech Health X recently had the opportunity to sit down with Lan Su, the newly appointed Chief Operating…
Voyager Therapeutics (VYGR) Reports $24.6M in Q3 2024 Collaboration Revenues
Voyager Therapeutics Inc. (VYGR) is a pioneering biotechnology company at the forefront of developing innovative gene therapies for…
aTyr Pharma (ATYR) Raises $19.4 Million to Support Drug Development and Clinical Trials
aTyr Pharma Inc. (ATYR) is a pioneering clinical-stage biopharmaceutical company dedicated to developing novel, first-in-class therapies for patients…